Targeting the Host Adenosine A2A Receptor to Protect Against Fatal Rickettsiosis Using an Approved Parkinson's Disease Drug

Project: Other project

StatusActive
Effective start/end date5/8/184/30/20

Funding

  • National Inst of Allergy & Infectious Di: $220,787.58